TD Cowen initiated coverage of Carlyle with a Market Perform rating and $42 price target. The company offers an outsized net realization opportunity, while its building insurance/credit and secondaries are scaling against mixed private equity lead indicators, though the key wildcard would be whether its management seeks to re-engineer comp structure to bolster its fee-related earnings, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CG:
- Carlyle, Insight Partners to invest in Exiger
- Carlyle, Insight acquire Exiger in deal valuing company at $1.2B, WSJ says
- Carlyle’s Rubenstein in negotiations to buy Baltimore Orioles, Bloomberg reports
- Carlyle to replace ICU Medical in S&P 400 at open on 11/30
- Carlyle downgraded to In Line from Outperform at Evercore ISI
Questions or Comments about the article? Write to editor@tipranks.com